Cargando…

Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis

OBJECTIVE: Rosiglitazone (RSG) is an insulin-sensitizing drug used to treat type 2 diabetes mellitus. The A Diabetes Outcome Progression Trial (ADOPT) shows that women taking RSG experienced more fractures than patients taking other type 2 diabetes drugs. These were not osteoporotic vertebral fractu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sardone, Laura D., Renlund, Richard, Willett, Thomas L., Fantus, Ivan G., Grynpas, Marc D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219933/ https://www.ncbi.nlm.nih.gov/pubmed/21998400 http://dx.doi.org/10.2337/db10-1672

Ejemplares similares

Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
por: Sarruf, David A., et al.
Publicado: (2010)

In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010)

Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance
por: Ho, David, et al.
Publicado: (2015)

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006)

Insulin Reduces Cerebral Ischemia/Reperfusion Injury in the Hippocampus of Diabetic Rats: A Role for Glycogen Synthase Kinase-3β
por: Collino, Massimo, et al.
Publicado: (2009)

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
por: Si, Yiling, et al.
Publicado: (2012)

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
por: Holden, Sarah E, et al.
Publicado: (2011)

Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy
por: Brierley, Gemma V., et al.
Publicado: (2020)

Oral Therapeutics Post Menopausal Osteoporosis
por: Schroeder, Ryan J, et al.
Publicado: (2023)

Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog
por: Edgerton, Dale S., et al.
Publicado: (2014)

Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro
por: He, Qichen, et al.
Publicado: (2022)

Recommendations for the Definition of Clinical Responder in Insulin Preservation Studies
por: Beam, Craig A., et al.
Publicado: (2014)

A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
por: Bhaskar, Vinay, et al.
Publicado: (2012)

Exercise-Linked Skeletal Irisin Ameliorates Diabetes-Associated Osteoporosis by Inhibiting the Oxidative Damage–Dependent miR-150-FNDC5/Pyroptosis Axis
por: Behera, Jyotirmaya, et al.
Publicado: (2022)

Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo
por: Konstantopoulos, Nicky, et al.
Publicado: (2012)

Identification of a Small Molecular Insulin Receptor Agonist With Potent Antidiabetes Activity
por: Qiang, Guifen, et al.
Publicado: (2014)

Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study
por: Mamza, J, et al.
Publicado: (2014)

Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid
por: Kasai, Hidefumi, et al.
Publicado: (2020)

Safer medicines To reduce falls and refractures for OsteoPorosis (#STOP): a study protocol for a randomised controlled trial of medical specialist-initiated pharmacist-led medication management reviews in primary care
por: Moles, Rebekah Jane, et al.
Publicado: (2023)

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
por: Sosenko, Jay M., et al.
Publicado: (2020)

Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice
por: Tan, Carina P., et al.
Publicado: (2008)

Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
por: Duan, Franklin F., et al.
Publicado: (2015)

Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice
por: Gómez-Valadés, Alicia G., et al.
Publicado: (2008)

Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes
por: Spectre, Galia, et al.
Publicado: (2012)

Proinsulin-Transferrin Fusion Protein as a Novel Long-Acting Insulin Analog for the Inhibition of Hepatic Glucose Production
por: Wang, Yan, et al.
Publicado: (2014)

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
por: Christensen, Alexander S., et al.
Publicado: (2020)

Phenotypic Type 2 Diabetes in Obese Youth: Insulin Sensitivity and Secretion in Islet Cell Antibody–Negative Versus –Positive Patients
por: Tfayli, Hala, et al.
Publicado: (2009)

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
por: Xu, Jing, et al.
Publicado: (2009)

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes
por: Chow, Elaine, et al.
Publicado: (2023)

Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
por: Cittadini, Antonio, et al.
Publicado: (2012)

Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes
por: Serrano-Marco, Lucía, et al.
Publicado: (2011)

Effects of Salsalate Therapy on Recovery From Vascular Injury in Female Zucker Fatty Rats
por: Murthy, Subramanyam N., et al.
Publicado: (2010)

Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis
por: Loke, Yoon K, et al.
Publicado: (2015)

Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction
por: Baselet, Bjorn, et al.
Publicado: (2020)

Process mapping evaluation of medication reconciliation in academic teaching hospitals: a critical step in quality improvement
por: Holbrook, Anne, et al.
Publicado: (2016)

Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats
por: Tong, Miao, et al.
Publicado: (2012)

Applying quality improvement methods to address gaps in medicines reconciliation at transfers of care from an acute UK hospital
por: Marvin, Vanessa, et al.
Publicado: (2016)

Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
por: Cummings, Bethany P., et al.
Publicado: (2010)

Association between HIV and treatment-resistant hypertension in Malawian adults: a protocol for a case–control study
por: Gondwe, Josephine, et al.
Publicado: (2023)

Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study
por: Kloprogge, Frank, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a6kr6dka9g416f1g4h5bfirkqe